Fabiola Palma-Trujillo

Fabiola Palma-Trujillo serves as a key procurement lead within the W40M MRC0 West agency under the Department of the Army, responsible for securing critical medical readiness capabilities essential to operational field medicine. She manages the acquisition of in-vitro diagnostic substances, surgical instruments, sterilization systems, and blood management technologies that enable high-acuity care in deployed environments. Her work ensures the Army’s medical forces remain equipped with FDA-regulated, clinically validated tools that support diagnostic accuracy, procedural safety, and rapid response under austere conditions. She operates within a mission-driven framework prioritizing technical reliability, supply chain resilience, and compliance with military medical standards. Palma-Trujillo maintains consistent relationships with leading medical technology providers including Roche Diagnostics Corporation, Cardinal Health 414, LLC, and Surgical Neuromonitoring Associates, Inc., reflecting a preference for established manufacturers and specialized service providers with proven capabilities in military-grade medical systems. Her contracting patterns emphasize long-term vendor partnerships with firms possessing deep expertise in diagnostic reagents, sterile instrument processing, and intraoperative monitoring technologies. She frequently engages suppliers with FDA 510(k) or CE-marked products, ensuring regulatory alignment and interoperability with Army medical platforms. Her contracting activity is overwhelmingly non-set-aside, with 96% of awards issued under full and open competition, indicating a primary focus on technical merit and mission-critical performance over socioeconomic preferences. Only 4% of awards are designated for Service-Disabled Veteran-Owned Small Businesses, suggesting a targeted, rather than broad, small business engagement strategy aligned with the specialized nature of her portfolio. Her procurement focus centers on NAICS 325412 (Pharmaceutical Preparation Manufacturing) and 325413 (In-Vitro Diagnostic Substance Manufacturing), with significant activity in 339112 (Surgical and Medical Instrument Manufacturing). She routinely acquires precision diagnostic kits, automated sterilization equipment, and neuromonitoring systems, demonstrating deep technical familiarity with clinical laboratory workflows, surgical instrumentation standards, and medical device lifecycle management.